EUVIMEDEUVIMED entdecken
Crossref

Advancements And Challenges In Peptide Therapeutics: Pioneering Precision Medicine For Oncology And Endocrinology

S Radhakrishnan, R Sambathkumar, C Kannan, R K Hariprasath, S Govindaraj, R Hari Vigneshwaran, C Santhosh, R Vishnu

International Journal of Drug Delivery Technology · 14.04.2026 · 16 (9s)

DOI: 10.25258/ijddt.16.9s.95 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.04.2026. Verfasst von S Radhakrishnan und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptide-based treatments are a rising group of biologic medications that are known for being specific, effective, and safe. These drugs are made up of short sequences of amino acids that can act like natural hormones, enzymes, or other molecules that are active in the body. To make peptide pharmaceuticals, strict quality standards must be met, such as purity, activity, stability, solubility, and control of contaminants. Regulatory channels, like those set up by the FDA and EMA, make sure that these products go through thorough clinical trials and follow Good Manufacturing Practice (GMP) to make sure they are safe and effective. Recent improvements in peptide manufacturing and formulation technology have made these medications useful in more ways than ever before. New delivery techniques, like nanoparticle carriers and sustained-release formulations, are making peptides more stable and easier for the body to use. Also, the capacity to make peptides that target certain disease pathways or biomarkers opens the door to tailored and focused treatments. Peptide therapies have a bright future, as research continues to look at their usage in a wide range of medical fields, such as oncology, metabolic disorders, and infectious diseases. As the field grows, peptide-based drugs are likely to become available as new treatments. Keywords: Peptide therapeutics, quality specifications, regulatory considerations, targeted therapies, personalized medicine

Zitieren

APA

Radhakrishnan, S., Sambathkumar, R., Kannan, C., Hariprasath, R. K., Govindaraj, S., Vigneshwaran, R. H., Santhosh, C., & Vishnu, R. (2026). Advancements And Challenges In Peptide Therapeutics: Pioneering Precision Medicine For Oncology And Endocrinology. International Journal of Drug Delivery Technology, 16(9s). https://doi.org/10.25258/ijddt.16.9s.95

Vancouver

Radhakrishnan S, Sambathkumar R, Kannan C, Hariprasath RK, Govindaraj S, Vigneshwaran RH, et al. Advancements And Challenges In Peptide Therapeutics: Pioneering Precision Medicine For Oncology And Endocrinology. International Journal of Drug Delivery Technology. 2026;16(9s). doi:10.25258/ijddt.16.9s.95

BibTeX
@article{Radhakrishnan2026,
  author = {Radhakrishnan, S and Sambathkumar, R and Kannan, C and Hariprasath, R K and Govindaraj, S and Vigneshwaran, R Hari and Santhosh, C and Vishnu, R},
  title = {Advancements And Challenges In Peptide Therapeutics: Pioneering Precision Medicine For Oncology And Endocrinology},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {9s},
  doi = {10.25258/ijddt.16.9s.95}
}
Kostenlos starten →